Antiplatelet therapy or low-dose heparin and neuraxial anaesthesia

Acta Anaesthesiol Scand Suppl. 1997:111:219-21.
No abstract available

MeSH terms

  • Anesthesia, Epidural* / adverse effects
  • Anesthesia, Spinal* / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Aspirin / administration & dosage
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Blood Coagulation Disorders / complications
  • Hematoma, Epidural, Cranial / etiology
  • Hematoma, Subdural / etiology
  • Heparin / administration & dosage
  • Heparin / adverse effects
  • Heparin / therapeutic use*
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Risk Assessment
  • Risk Factors
  • Thrombocytopenia / complications
  • Thrombosis / complications
  • Thrombosis / prevention & control

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Platelet Aggregation Inhibitors
  • Heparin
  • Aspirin